Literature DB >> 20331641

Neutrophil antimicrobial proteins enhance Shigella flexneri adhesion and invasion.

Björn Eilers1, Anne Mayer-Scholl, Travis Walker, Christoph Tang, Yvette Weinrauch, Arturo Zychlinsky.   

Abstract

Shigella flexneri is an enteric pathogen that causes massive inflammation and destruction of the human intestinal epithelium. Neutrophils are the first cells of the innate immune system recruited to the site of infection. These cells can attack microbes by phagocytosis, Neutrophil Extracellular Trap (NET) formation and degranulation. Here, we investigated how neutrophil degranulation affects virulence and show that exposure of Shigella to granular proteins enhances infection of epithelial cells. During this process, cationic granular proteins bind to the Shigella surface causing increased adhesion which ultimately leads to hyperinvasion. This effect is mediated by changes in the surface charge, since a lipopolysaccharide (LPS) mutant with a negative surface shows enhanced hyperinvasion compared with wild-type Shigella. We propose that Shigella evolved to use host defence molecules to enhance its virulence and subvert the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20331641     DOI: 10.1111/j.1462-5822.2010.01459.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  12 in total

1.  Afa/Dr diffusely adhering Escherichia coli strain C1845 induces neutrophil extracellular traps that kill bacteria and damage human enterocyte-like cells.

Authors:  Viviana Marin-Esteban; Isabelle Turbica; Guillaume Dufour; Nicolas Semiramoth; Aude Gleizes; Roseline Gorges; Isabelle Beau; Alain L Servin; Vanessa Lievin-Le Moal; Catherine Sandré; Sylvie Chollet-Martin
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

Review 2.  Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas.

Authors:  Margaret Kosek; Pablo Peñataro Yori; Maribel Paredes Olortegui
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

Review 3.  LBP/BPI proteins and their relatives: conservation over evolution and roles in mutualism.

Authors:  Benjamin C Krasity; Joshua V Troll; Jerrold P Weiss; Margaret J McFall-Ngai
Journal:  Biochem Soc Trans       Date:  2011-08       Impact factor: 5.407

4.  A new understanding of enteroaggregative Escherichia coli as an inflammatory pathogen.

Authors:  Erik J Boll; Beth A McCormick
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

5.  Detection of Cytosolic Shigella flexneri via a C-Terminal Triple-Arginine Motif of GBP1 Inhibits Actin-Based Motility.

Authors:  Anthony S Piro; Dulcemaria Hernandez; Sarah Luoma; Eric M Feeley; Ryan Finethy; Azeb Yirga; Eva M Frickel; Cammie F Lesser; Jörn Coers
Journal:  mBio       Date:  2017-12-12       Impact factor: 7.867

Review 6.  Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview.

Authors:  Vidal Delgado-Rizo; Marco A Martínez-Guzmán; Liliana Iñiguez-Gutierrez; Alejandra García-Orozco; Anabell Alvarado-Navarro; Mary Fafutis-Morris
Journal:  Front Immunol       Date:  2017-02-06       Impact factor: 7.561

Review 7.  Defensins: A Double-Edged Sword in Host Immunity.

Authors:  Dan Xu; Wuyuan Lu
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

Review 8.  Sub-inhibitory Effects of Antimicrobial Peptides.

Authors:  Alexey S Vasilchenko; Eugene A Rogozhin
Journal:  Front Microbiol       Date:  2019-05-24       Impact factor: 5.640

9.  NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury.

Authors:  Nikolaos G Almyroudis; Melissa J Grimm; Bruce A Davidson; Marc Röhm; Constantin F Urban; Brahm H Segal
Journal:  Front Immunol       Date:  2013-03-01       Impact factor: 7.561

10.  Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.

Authors:  Wataru Aoki; Mitsuyoshi Ueda
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.